ConductScience.org, home

Paper82578

Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.

Perry LL and 2 others. J Immunol, 1978. Cited by 77 papers, by iCite.

Cite this record

ConductScience Library. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo. Papers, record 82578. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/82578

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.
PubMed
Journal
J Immunol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2006-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perry LLL L
2Benacerraf BB
3Greene MIM I

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
EpitopesMajor topic
Immunity, CellularMajor topic
T-LymphocytesMajor topic
Animals
Fibrosarcoma
Major Histocompatibility Complex
Mice
Mice, Inbred A

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
7075024Immunological studies in typhoid fever. II. Cell-mediated immune responses and lymphocyte subpopulations in patients with typhoid fever.Clin Exp Immunol1982https://conductscience.org/library/papers/7075024PubMed
6982059Tumour-induced changes in murine lymphocyte profiles.Br J Cancer1982https://conductscience.org/library/papers/6982059PubMed
6972040Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6972040PubMed
6792727Helper and suppressor T cell factors.Springer Semin Immunopathol1980https://conductscience.org/library/papers/6792727PubMed
6761008Immune complexes in Indian kala-azar.Bull World Health Organ1982https://conductscience.org/library/papers/6761008PubMed
6609731Patterns of T cell subset alterations in myelo- and lymphoproliferative disorders.Blut1984https://conductscience.org/library/papers/6609731PubMed
6458813Suppressor factor from a T cell hybrid inhibits delayed-type hypersensitivity responses to azobenzenearsonate.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6458813PubMed
6446719T-T hybridoma product specifically suppresses tumor immunity.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6446719PubMed
6445400Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor.J Exp Med1980https://conductscience.org/library/papers/6445400PubMed
6445398Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors.J Exp Med1980https://conductscience.org/library/papers/6445398PubMed
6444236T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.J Exp Med1980https://conductscience.org/library/papers/6444236PubMed
6293112Regulation of the immune response to antigens on the malignant cell surface.Springer Semin Immunopathol1982https://conductscience.org/library/papers/6293112PubMed
6217278Regulation of granulomatous inflammation in murine schistosomiasis. II. T suppressor cell-derived, I-C subregion-encoded soluble suppressor factor mediates regulation of lymphokine production.J Exp Med1983https://conductscience.org/library/papers/6217278PubMed
6212625Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies.J Exp Med1982https://conductscience.org/library/papers/6212625PubMed
6165799Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cells.J Exp Med1981https://conductscience.org/library/papers/6165799PubMed
6161877Antigen-specific T-cell factors.Immunology1980https://conductscience.org/library/papers/6161877PubMed
2931377Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression.Infect Immun1985https://conductscience.org/library/papers/2931377PubMed
2600981Investigation on the inhibitory effect of tumor-derived immunosuppressive factor(s) on T lymphocyte proliferation.J Tongji Med Univ1989https://conductscience.org/library/papers/2600981PubMed
312894Mechanisms of regulation of cell-mediated immunity. III. The characterization of azobenzenearsonate-specific suppressor T-cell-derived-suppressor factors.J Exp Med1979https://conductscience.org/library/papers/312894PubMed
106399Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/106399PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/82578

GET https://conductscience.org/api/papers/v1/82578/authors